Last reviewed · How we verify

NCT03193034

DSJ-2016-07 ATTUNE® Cementless CR RP Japan

Completed NA Last updated 29 September 2021
What this trial tests

NA trial testing Cementless Total Knee Arthroplasty in Osteoarthritis in 81 participants. Completed in 30 June 2021.

Timeline
30 June 2017
Primary endpoint
22 December 2020
30 June 2021

Quick facts

Lead sponsorDePuy Orthopaedics
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment81
Start date30 June 2017
Primary completion22 December 2020
Estimated completion30 June 2021
Sites4 locations across Japan

Drugs / interventions tested

Conditions studied

Sponsor

DePuy Orthopaedics — full company profile →

Who can join

Adults 22 to 80, any sex, with Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective is to investigate the change from pre-operative baseline to two year postoperative functional performance improvement for the ATTUNE® primary, cementless TKA RP system as measured with the KOOS questionnaire (KOOS-ADL sub-score) in the Japanese patient population.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Clinical outcomes and radiolucent line analysis in cementless mobile-bearing total knee arthroplasty: a prospective multicentre study in Japan.
    Minoda Y, Nakagawa S, Ueyama H, Warashina H, et al · · 2024 · cited 3× · PMID 39245768 · DOI 10.1038/s41598-024-71806-4

Verify or expand the search:

Other trials of Cementless Total Knee Arthroplasty

Trials testing the same drug.

Other recruiting trials for Osteoarthritis

Currently open trials in the same condition.

Other DePuy Orthopaedics trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03193034.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing